Suhail Alkilani, MD
Sleep Medicine · Fort Myers, FLNPI 1942514666
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.4% of the total across 45 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by Harmony Biosciences LLC at 26.5% of the total. Reporting peaked in 2022 at $706 and has fallen 51.8% since, to $340 in 2025. That places this record below the midpoint for sleep medicine clinicians in FL, where the typical reported total is $1,804.
Across 45 payments — averaging $30.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Harmony Biosciences LLC$366
- Jazz Pharmaceuticals Inc.$254
- AstraZeneca$189
- AbbVie$126
- Boehringer Ingelheim$84
- Sunovion Pharmaceuticals Inc.$61
- plus $302 from 12 others
What the payments were for
- Food & beverage$1,36098%
- Education$222%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Harmony Biosciences LLC | 14 | $366 |
| Jazz Pharmaceuticals Inc. | 6 | $254 |
| AstraZeneca | 2 | $189 |
| AbbVie | 4 | $126 |
| Boehringer Ingelheim | 1 | $84 |
| Sunovion Pharmaceuticals Inc. | 3 | $61 |
| Resmed Corp | 3 | $60 |
| Itamar Medical Inc | 1 | $33 |
| Eisai Inc. | 2 | $33 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $25 |
| Novartis | 1 | $23 |
| Bristol Myers Squibb | 1 | $23 |
| SK Life Science, Inc. | 1 | $20 |
| CSL Behring | 1 | $19 |
| Biohaven Pharmaceuticals, Inc. | 1 | $19 |
| E.r. Squibb & Sons, L.L.C. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Genentech USA, Inc. | 1 | $12 |
How this compares
$1,382 in reported general payments places this provider in the 35th percentile of 77 sleep medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Eszopiclone | 11 | $118 |
| Trazodone Hcl | 13 | $34 |
Paid to pharmacies, not to this prescriber.
Other sleep medicine in Fort Myers
- Fariha Abbasi-FeinbergFort Myers$6K
- Javaad KhanFort Myers$1K
- Michael SandFort Myers$1K
- Jeremy McConnellBradenton$615K
- Edward MezerhaneMiami$537K
- Shane DrahosWinter Garden$317K
- Kunal AgarwalSarasota$153K
- Camilo RuizFort Lauderdale$136K
- Sergio JaramilloMiami$32K
- Carlos Ramirez MejiaMiami$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.